Document is current
Any future updates will be listed below
-
Authors
Rachamala, Hari Krishnareddy
Nakka, Naga Malleswara Rao
Dutta, Shamit Kumar
Wang, Enfeng
Mukhopadhyay, Debabrata
Pal, Krishnendu https://orcid.org/0000-0002-4006-213X
-
Funding
Funding for this research was provided by:
Congressionally Directed Medical Research Programs (W81XWH-21-1-0678)
National Heart, Lung, and Blood Institute (R56HL160545)
Florida Department of Health (91803004)
- License Information
-
More Information
Article History
Received: 8 August 2025
Accepted: 21 November 2025
First Online: 2 December 2025
Declarations
:
: All procedures involving animals were conducted in accordance with the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) guidelines and were approved by the Institutional Animal Care and Use Committee (IACUC) at the Mayo Clinic.
: The content of this manuscript has not been previously published and is not under consideration for publication elsewhere. All authors read and approved the final manuscript for publication.
: DM and KP have filed for intellectual property protection related to the tumor-targeted liposomal formulation presented in this manuscript. The authors declare no other conflicts of interest.
